OpenVSafe by OpenVAERS
Search V-safe

6C2-16011-06248

2 vaccinations 7 coded responses 18 check-ins 7 free-text entries 0 call cases
Sex
Male
Age at first dose
36-40
ZIP prefix
170 / PA
Registered
2021-02-11
Relationship
Self
Race
Multiracial
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-11
    Registered in v-safe
  2. 2021-02-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-11
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  4. 2021-02-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain
    Free text: Runny nose outside in the cold; psychomotor agitation at mild to moderate intensity throughout the day
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-18
    Survey response — day 7, dose 1
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Mild nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-25
    Survey response — day 14, dose 1
    MedDRA: Respiratory tract congestion, Rhinorrhoea, Throat irritation — Feeling: Good
    Free text: Congestion, runny nose, tickle in throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-04
    Dose 2 — Pfizer-BioNTech
  10. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: Muscles around Injection site painful to touch
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-16
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-03
    Survey response — 3 months, dose 2
    MedDRA: Insomnia, Lacrimation increased, Paranasal sinus inflammation, Pre-existing disease, Rhinorrhoea, Sinus headache — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Feels like extreme allergy reaction; inflamed sinuses, excessive fluid from nose and eyes; sinus headache; unable to sleep; minimal relief from loratidine and other allergy medications.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-11Pfizer-BioNTech
22021-03-04Pfizer-BioNTech

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-12

Systemic reaction (other): Runny nose outside in the cold; psychomotor agitation at mild to moderate intensity throughout the day

Release 4 — day 7, dose 1

2021-02-18

Systemic reaction (other): Mild nasal congestion

Release 4 — day 14, dose 1

2021-02-25

Symptoms: Congestion, runny nose, tickle in throat

Release 5 — days 1–6 daily, dose 2

2021-03-05

Systemic reaction (other): Runny nose

2021-03-06

Systemic reaction (other): Runny nose

2021-03-09

Systemic reaction (other): Muscles around Injection site painful to touch

Release 8 — 3 months, dose 2

2021-06-03

Symptoms: Feels like extreme allergy reaction; inflamed sinuses, excessive fluid from nose and eyes; sinus headache; unable to sleep; minimal relief from loratidine and other allergy medications.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInsomnia ✓ ✓ ✓
SDLacrimation increased ✓ ✓ ✓
SDParanasal sinus inflammation ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SDSinus headache ✓ ✓ ✓
SDThroat irritation ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…